Blog

SPOT-MAS NEWS

Transforming Cancer Screening: When AI and ctDNA Technology Met

Read More

Evaluation of a multimodal ctDNA-based assay for detection of aggressive cancers lacking standard screening tests

Current cancer screening methods are predominantly organ specific, utilizing diagnostic imaging tests with multiple modalities.
Read More

Effective Clinical Follow-Up for ctDNA Multi-Cancer Early Detection Test: A Peer-Reviewed Study of Post-Test Standard Operating Procedure and Real-Life Results

Current cancer screening methods are predominantly organ specific, utilizing diagnostic imaging tests with multiple modalities.
Read More

Pioneering a Tumor-Specific Methylation Atlas (TSMA) to Identify Tissue of Origin (TOO) in Multi-Cancer Early Detection

Cell free DNA (cfDNA)-based assays hold great potential in detecting early cancer signals. However, predicting the tissue-of-origin for multiple cancer types at an early stage remains challenging due to the low abundance of tumor- derived cfDNA and the confounding presence of various DNA components released from non- tumor sources.
Read More

Gene Solutions News

Real-world example from SPOT-MAS test results(7)​

“I had no personal or family history of cancer, but I decided to take the SPOT-MAS test. It detected ctDNA signals that pointed to possible tumors in my stomach and lung. I then underwent a gastroscopy and biopsy, which confirmed poorly differentiated signet ring cell adenocarcinoma in my stomach. I had a total gastrectomy with D2 lymph node dissection, and the post-surgery analysis showed that the cancer had already spread to my lymph nodes.

This experience made me realize how silent stomach cancer can be—and how critical early detection with SPOT-MAS truly is.”
Test taker with positive result
Test taker with positive resultLim
“My mother passed away from stage IV ovarian cancer. Since there’s no regular screening available for this type of cancer, it was only discovered when it was already too late. After that, I lived with constant fear and anxiety — wondering if I might have cancer too. That’s why I decided to take the SPOT-MAS test.

When I received a negative result, I felt an overwhelming sense of relief and joy. I know I can’t control everything, but I can take action. From now on, I plan to do annual screenings. If anything ever appears, I want to catch it early — when it’s still treatable.”
Test taker with negative result
Test taker with negative resultJane
Disclaimer: Names and images have been changed to protect the privacy of individuals. The stories are based on real SPOT-MAS test results.

(7) Luu Hong Dang Nguyen et al. 2024. A consultation and work-up diagnosis protocol for a multicancer early detection test: a case series study. Future Science OA, 10 (1).

SPOT-MAS Videos

Test Process

01

Request the test

Request the test through your primary care doctor. A prescription and 10ml blood collection are required.

02

Sequencing of cfDNA

Your extracted DNA from the plasma will be sequenced by Next–generation ctDNA technology to analyze multi–feature of DNA.

03

Returning results

Receive your ctDNA signal analysis results after 20 working days from the time sample is received at Gene Solutions Genomics Singapore laboratory.

SPOT-MAS video